297 related articles for article (PubMed ID: 18211720)
1. Treatment of isoniazid-resistant pulmonary tuberculosis.
Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Lim SY; Lim SY; Koh WJ
BMC Infect Dis; 2008 Jan; 8():6. PubMed ID: 18211720
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Kim S; Lee H; Park HY; Jeon K; Huh HJ; Lee NY; Jeong BH
Respir Med; 2017 Dec; 133():6-11. PubMed ID: 29173450
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
5. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
6. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and transmission of pyrazinamide-resistant
Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
[No Abstract] [Full Text] [Related]
8. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Munir S; Mahmood N; Shahid S; Khan MI
Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Cao R; Teskey G; Islamoglu H; Abrahem R; Munjal S; Gyurjian K; Zhong L; Venketaraman V
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126957
[No Abstract] [Full Text] [Related]
11. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Park JS; Lee JY; Lee YJ; Kim SJ; Cho YJ; Yoon HI; Lee CT; Song J; Lee JH
Antimicrob Agents Chemother; 2016 Jan; 60(1):92-8. PubMed ID: 26459901
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
[TBL] [Abstract][Full Text] [Related]
14. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
15. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
16. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
Wan L; Guo Q; Wei JH; Liu HC; Li MC; Jiang Y; Zhao LL; Zhao XQ; Liu ZG; Wan KL; Li GL; Guan CX
Infect Dis Poverty; 2020 Apr; 9(1):38. PubMed ID: 32299480
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment.
Zhang G; Sun X; Fleming J; Ran F; Luo J; Chen H; Ju H; Wang Z; Zhao H; Wang C; Zhang F; Dai X; Yang X; Li C; Liu Y; Wang Y; Zhang X; Jiang Y; Wu Z; Bi L; Zhang H
Clin Microbiol Infect; 2024 May; 30(5):637-645. PubMed ID: 38286176
[TBL] [Abstract][Full Text] [Related]
19. Change in demographic picture and increase of drug resistance in pulmonarytuberculosis in a 10-year interval in Taiwan.
Tsao TC; Chiou W; Lin H; Wu T; Lin M; Yang P; Tsai Y
Infection; 2002 Apr; 30(2):75-80. PubMed ID: 12018473
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
